Author:
de Lissovoy Greg,Fraeman Kathy,Teerlink John R.,Mullahy John,Salon Jeff,Sterz Raimund,Durtschi Amy,Padley Robert J.
Publisher
Springer Science and Business Media LLC
Subject
Health Policy,Economics, Econometrics and Finance (miscellaneous)
Reference17 articles.
1. Rosamond, W., Flegal, K., Friday, G., et al.: Heart disease and stroke statistics—2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115, e69–e171 (2007). doi:
10.1161/CIRCULATIONAHA.106.179918
2. Bayram, M., De Luca, L., Massie, M.B., Gheorghiade, M.: Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. Am. J. Cardiol. 96, 47G–58G (2005). doi:
10.1016/j.amjcard.2005.07.021
3. Follath, F., Cleland, J.G., Just, H., et al.: Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360, 196–202 (2002). doi:
10.1016/S0140-6736(02)09455-2
4. Packer, M.: REVIVE II: Multicenter Placebo-controlled Trial of Levosimendan on Clinical Status in Acutely Decompensated Heart Failure. In: Program and abstracts from the American Heart Association Scientific Sessions 2005 Dallas (2005)
5. de Lissovoy, G., Fraeman, K., Sterz, R., Durtschi, A., Mullahy, J.: Estimating cost of hospital treatment for patients in a randomized clinical trial. In: Presented at the International Health Economics Association’s 6th World Congress: Explorations in Health, Copenhagen (2007)
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献